Investors

Shareholder Information

Incanthera plc's shares are traded on the Access Segment of AQSE Exchange Growth Market, Updated as of 18 August 2022.

Symbol: INC

ISIN GB00BGL7YW15
LEI code 2138002HEV4UFBOEXQ97

There are no restrictions on the transfer of AQSE Securities.

The main country of operation is United Kingdom. Incorporated and registered in England and Wales with registered number 11026926.

Incanthera plc is subject to the City Code on Takeovers and Mergers.

Shareholder Analysis

No. of shares in issue: 74,082,871
Warrants outstanding: 18,752,380
Options outstanding: 7,214,000
Fully diluted: 100, 049,251
Percentage of Shares in public hands: 43.95%
Percentage of Shares not in public hands: 56.05%

Major Shareholdings

Shareholder Number of shares held % of issued share capital
North West Funds (Biomedical) LP 16,164,540 21.8%
ImmuPharma plc 9,903,349 13.4%
University of Bradford 7,492,040 10.1%
JIM Nominees Limited 6,385,156 8.6%
Pershing Nominees Limited 4,075,750 5.5%
Timothy McCarthy 3,931,646 5.3%
Simon Ward 2,704,199 3.7%
Gateley plc 2,239,295 3.0%

Contact:

Head of Communications & Company Secretary
Suzanne Brocks
Suzanne.brocks@incanthera.com